As of March 31, 2026, Airway Medix SA carries a market capitalization of 34.88M, placing it among publicly traded companies globally. Its enterprise value stands at 48.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 34.88M |
| Enterprise Value | 48.07M |
As of March 31, 2026, Airway Medix SA has 115.11M shares outstanding.
| Shares Outstanding | 115.11M |
These figures are as of March 31, 2026.
| PB Ratio | -3.44 |
| P/TBV Ratio | -1.73 |
As of March 31, 2026, Airway Medix SA maintains a current ratio of 0.07, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.07 |
| Quick Ratio | 0.02 |
| Debt / Equity | -134.12 |
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 1.00 |
As of the close on October 22, 2026, Airway Medix SA's stock has declined approximately 32.16% over the past 52 weeks. The 50-day moving average sits at 0.26, while the 200-day moving average is 0.28.
| 52-Week Price Change | -32.16% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.28 |
As of March 31, 2026, Airway Medix SA holds 401,000.00 in cash and equivalents against 13.59M in total debt, resulting in a net debt position of 12.83M. Total book value stands at -10.13M, with working capital of -17.02M providing operational flexibility.
| Cash & Cash Equivalents | 401,000.00 |
| Total Debt | 13.59M |
| Net Debt | 12.83M |
| Equity (Book Value) | -10.13M |
| Book Value Per Share | -0.09 |
| Working Capital | -17.02M |
These figures cover the twelve months ended March 31, 2026.
| Capital Expenditures | -60,000.00 |
Already premium?